COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Bill of Health
JANUARY 12, 2023
Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Indeed, as made public, the U.S. Moderna has since made over $30 billion in COVID-19 vaccine sales. By Aparajita Lath.
Let's personalize your content